Tokyo, March 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059805) titled 'Patient-Reported Outcomes in Patients with Metastatic Colorectal Cancer Treated with Fruquintinib: A Prospective Observational Study' on March 1.
Study Type:
Observational
Primary Sponsor:
Institute - Aichi Cancer Network
Condition:
Condition - Metastatic colorectal cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To collect and analyze patient-reported outcomes (PROs) during fruquintinib treatment in patients with colorectal cancer, thereby elucidating adverse events and impacts on quality of life from the patient's perspective. This will support indivi...